Literature DB >> 17678720

Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: longitudinal study during pregnancy.

Estibaliz Alegre1, Angel Díaz-Lagares, Joel Lemaoult, Natalia López-Moratalla, Edgardo D Carosella, Alvaro González.   

Abstract

The aim of this work was to investigate the longitudinal evolution of plasmatic soluble HLA-G (sHLA-G: shed HLA-G1 plus HLA-G5) during pregnancy, and if peripheral maternal antigen presenting cells (APC) can be a source of sHLA-G. Blood samples were obtained from 45 volunteers during normal pregnancy, 8 of them monthly; from 8 pregnant volunteers in the first weeks of pregnancy who had later a miscarriage, and from 14 healthy nonpregnant control women. Monocytes obtained during pregnancy showed a moderately HLA-G cell surface expression and stimulation with interferon (IFN)-gamma increased this expression. Monocytes-derived dendritic cells obtained from pregnant women during the first and third trimester of pregnancy secreted more sHLA-G than those obtained from nonpregnant women. Plasmatic sHLA-G concentration in pregnant women was significatively higher than in nonpregnant women, with a peak in the third month. We can conclude that maternal APC are a source of sHLA-G. Women who experienced miscarriage had previously very low or undetectable plasmatic sHLA-G levels in the second month of pregnancy. Data suggest that undetectable sHLA-G could be a risk of complications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17678720     DOI: 10.1016/j.humimm.2007.04.007

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  14 in total

Review 1.  The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells.

Authors:  Roberta Rizzo; Martine Vercammen; Hilde van de Velde; Peter A Horn; Vera Rebmann
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

Review 2.  Impact of HLA-G analysis in prevention, diagnosis and treatment of pathological conditions.

Authors:  Daria Bortolotti; Valentina Gentili; Antonella Rotola; Enzo Cassai; Roberta Rizzo; Dario Di Luca
Journal:  World J Methodol       Date:  2014-03-26

3.  HLA-G polymorphisms and soluble HLA-G protein levels in women with recurrent pregnancy loss from Basrah province in Iraq.

Authors:  Raghed M Jassem; Wafaa Sadoon Shani; Dagan A Loisel; Maysoon Sharief; Christine Billstrand; Carole Ober
Journal:  Hum Immunol       Date:  2012-05-28       Impact factor: 2.850

4.  Nitric oxide produces HLA-G nitration and induces metalloprotease-dependent shedding creating a tolerogenic milieu.

Authors:  Angel Díaz-Lagares; Estibaliz Alegre; Joel LeMaoult; Edgardo D Carosella; Alvaro González
Journal:  Immunology       Date:  2008-09-01       Impact factor: 7.397

5.  The maternal HLA-G 1597ΔC null mutation is associated with increased risk of pre-eclampsia and reduced HLA-G expression during pregnancy in African-American women.

Authors:  Dagan A Loisel; Christine Billstrand; Kathleen Murray; Kristen Patterson; Tinnakorn Chaiworapongsa; Roberto Romero; Carole Ober
Journal:  Mol Hum Reprod       Date:  2012-09-21       Impact factor: 4.025

6.  Amniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammation.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Cristiano Jodicke; Shali Mazaki-Tovi; Edi Vaisbuch; Offer Erez; Pooja Mittal; Francesca Gotsch; Tinnakorn Chaiworapongsa; Sam S Edwin; Percy Pacora; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-12

Review 7.  HLA-G as a tolerogenic molecule in transplantation and pregnancy.

Authors:  Vera Rebmann; Fabiola da Silva Nardi; Bettina Wagner; Peter A Horn
Journal:  J Immunol Res       Date:  2014-07-21       Impact factor: 4.818

Review 8.  HLA Class Ib Molecules and Immune Cells in Pregnancy and Preeclampsia.

Authors:  Snezana Djurisic; Thomas Vauvert F Hviid
Journal:  Front Immunol       Date:  2014-12-23       Impact factor: 7.561

9.  Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses.

Authors:  Jonathan R Honegger; Seungtaek Kim; Aryn A Price; Jennifer A Kohout; Kevin L McKnight; Mona R Prasad; Stanley M Lemon; Arash Grakoui; Christopher M Walker
Journal:  Nat Med       Date:  2013-10-27       Impact factor: 53.440

Review 10.  Some basic aspects of HLA-G biology.

Authors:  Estibaliz Alegre; Roberta Rizzo; Daria Bortolotti; Sara Fernandez-Landázuri; Enrico Fainardi; Alvaro González
Journal:  J Immunol Res       Date:  2014-04-09       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.